Toxicity effect of silver nanoparticles on mice liver primary cell culture and HepG2 cell line

Iranian Journal of Pharmaceutical Research

Volumn 13, Issue 1, 2014, Pages 235-242

  Faedmaleki, Firouz ^a   Shirazi, Farshad H ^b   Salarian, Amir Ahmad ^c   Ashtiani, Hamidreza Ahmadi ^d   Rastegar, Hossein ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Cell viability; HepG2 cell line; Mtt assay; Nanotechnology; Primary liver cells of mice; Silver nanoparticle

Indexed keywords

SILVER NANOPARTICLE;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DOSE COMPARISON; HUMAN; HUMAN CELL; IC 50; MOUSE; MTT ASSAY; NONHUMAN;

EID: 84903642956     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Gerber C and Lang HP. How the doors to the nano-world were opened. Nat Nanotech. (2006) 1: 3-5.
2. Singh N, Manshian B and Jenkins GJS. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials. (2009) 30: 3891-3914.
3. Maqusood Ahamed, Mohamad S AlSalhi and MKJ. Siddiqui. Silver nanoparticle applications and human health (2009) 1841-1848.
4. Soohee Kim, Ji Eun Choi, Jinhee Choi, Kyu-Hyuck Chung, Kwangsik Park, Jongheop Yi and Doug-Young Ryu. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells (2009) 1076-1084.
5. Karla Chaloupka, Yogeshkumar Malam and Alexander M. Seifalian. Nanosilver as a new generation of nanoproduct in biomedical applications (2010) 28.
6. Korani M, Rezayat S. M and Arbabi Bidgoli S. Sub-chronic Dermal Toxicity of Silver Nanoparticles in Guinea Pig: Special Emphasis to Heart, Bone and Kidney Toxicities. Iran. J. Pharm. Res. (2013) 12: 511-519.
7. Wallace WE, Keane MJ, Murray DK, Chisholm WP, Maynard AD and Ong TM. Phospholipid lung surfactant and nanoparticle surface toxicity: Lessons from diesel soots and silicate dusts. J. Nanopart. Res. (2007) 9: 23-38.
8. Colvin VL. The potential environmental impact of engineered nanomaterials. Nature Biotechnol. (2003) 21: 1166-1170.
9. Nel A, Xia T, Madler L and Li N. Toxic potential of materials at the nanolevel. Scie. (2006) 311: 622-627.
10. Woodrow Wilson International Center for Scholars. A nanotechnology consumer products inventory (2007) Available from: URL: www. nanotechproject. org/consumerproducts.
11. Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP and Balasubramanya RJ. Functional finishing of cotton fabrics using silver nanoparticles. J. Nanosci. Nanotechnol. (2007) 7: 1893-1897.
12. Caterina Zanette Marco Pelin, Matteo Crosera, Gianpiero Adami, Massimo Bovenzi, Francesca Filon Larese and Chiara Florio. silver nanoparticles exert a long-lasting antiproliferative effect on humankeratinocyte HaCaT cell line. Toxicol. Vitro (2011). 25: 1053-1060.
13. Young Sook Lee, Dong Woon Kim, Young Ho Lee, Jung Hwa Oh, Seokjoo Yoon, Mi Sun Choi, Sung Kyu Lee and Ji Won Kim and Chang-Woo Song. Silver nanoparticles induce apoptosis and G2/Marrest via PKCf-dependent signaling in A549 lung cells. Kyuhong Lee. (2011) 85: 1529-1540.
14. A Haase, J Tentschert, H Jungnickel, P Graf, A Mantion, F Draude, J Plendl, ME Goetz, S Galla, A Masi, A F huenemann, A Taubert, HF Arlinghaus and A Luch. Toxicity of silver nanoparticles in human macrophages: uptake, intracellular distribution and cellular responses. J. Physics: Confer. Series (2011) 304.
15. Takenaka, S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P and Heyder J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. (2001) 4: 547-551.
16. Huang L. and Wen T. One-step synthesis of silver nanoparticles and poly(2, 5dimethoxyaniline) in poly(styrene sulfonic acid). Mater. Sci. Eng. A. (2007) 445-446: 7-13.
17. Kim YS, Kim JS and Cho HS. Twenty eight day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley Rats. Inhalation Toxicol. (2008) 20: 575-83.
18. Kim WY, Kim J, Park JD, Ryu HY and Yu IJ. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J. Toxicol. Environ. Health A. (2009) 72: 1279-1284.
19. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, Shin JH, Sung JH, Song KS and Yu IJ. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. (2007) 19: 857-871.
20. S Arora, J Jain, JM Rajwade and KM Paknikar-. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol. Applied Pharmacol. (2009) 236: 310-318.
21. chen X and Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol. Lett. (2008) 176: 1-12.
22. Lee KS and El-Sayed MA. Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. J. Phys. Chem. (2006) 110: 19220-19225.
23. Lee HY, Park HK, Lee YM, Kim K and Park SB. Apractical procedure for producing silver nanocoated fabric and its antibacterial evaluation for biomedical applications. Chem. Commun. (Camb). (2007) 28: 2959-2961.
24. Korbekandi H, Ashari Z, Iravani S and Abbasi S. Optimization of Biological Synthesis of Silver Nanoparticles using Fusarium oxysporum. Iran. J. Pharm. Res. (2013) 12: 289-298.
25. Sung JH, Ji JH and Yun JU. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol. (2008) 20: 567-74.
26. Hussain SM, Hess KL, Gearhart JM, Geiss KT and Schlager JJ. In-vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In-Vitro. (2005) 19: 975-983.
27. Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF and Schlager JJ. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol. Sci. (2006) 92: 456-463.
28. Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, Lim Y and Lee KH. Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhalation Toxicol. (2007) 19: 59-65.
29. Braydich-Stolle L, Hussain S, Schlager JJ and Hofmann MC. In-vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. (2005) 88: 412-419.
30. Trop M, Novak M, Rodl S, Hellbom B, Kroell W and Goessler W. Silvercoated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J. Trauma. (2006) 60: 648-652.
31. Carlson C, Hussain S and Schrand A. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B. (2008) 112: 13608-13619
32. Zurlo J and Arterburn LM. Characterization of a primary hepatocyte culture system for toxicological studies. In-Vitro Cell. Dev. Biol. (1996) 32: 211-220.
33. AshaRani PV, Low Kah Mun G, Hande MP and Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. (2009) 3: 279-290.
34. Shin SH, Ye MK, Kim HS and Kang HS. The effects of nanosilver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol. (2007) 7: 1813-1818.
35. Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, Domann E and Schnettler R. An in-vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials. (2004) 25: 4383-4391.
36. Feng QL, Wu j, Chen GQ, Cui FZ, Kim TN and Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. Jbio. med. mater. (2000) 52: 662-668.